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Background: Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection in young
children. The degree of disease severity is determined by the host response to infection. Lung macrophages play
an important early role in the host response to infection and we have used a systems-based approach to examine
the host response in RSV-infected lung-derived macrophage cells.
Results: Lung macrophage cells could be efficiently infected (>95%) with RSV in vitro, and the expression of several
virus structural proteins could be detected. Although we failed to detect significant levels of virus particle
production, virus antigen could be detected up until 96 hours post-infection (hpi). Microarray analysis indicated that
20,086 annotated genes were expressed in the macrophage cells, and RSV infection induced an 8.9% and 11.3%
change in the global gene transcriptome at 4 hpi and 24 hpi respectively. Genes showing up-regulated expression
were more numerous and exhibited higher changes in expression compared to genes showing down-regulated
expression. Based on gene ontology, genes with cytokine, antiviral, cell death, and signal transduction functions
showed the highest increases in expression, while signalling transduction, RNA binding and protein kinase genes
showed the greatest reduction in expression levels. Analysis of the global gene expression profile using pathway
enrichment analysis confirmed that up-regulated expression of pathways related to pathogen recognition,
interferon signalling and antigen presentation occurred in the lung macrophage cells challenged with RSV.
Conclusion: Our data provided a comprehensive analysis of RSV-induced gene expression changes in lung
macrophages. Although virus gene expression was detected, our data was consistent with an abortive infection
and this correlated with the activation of several antivirus signalling pathways such as interferon type I signalling
and cell death signalling. RSV infection induced a relatively large increase in pro-inflammatory cytokine expression,
however the maintenance of this pro-inflammatory response was not dependent on the production of infectious
virus particles. The sustained pro-inflammatory response even in the absence of a productive infection suggests
that drugs that control the pro-inflammatory response may be useful in the treatment of patients with severe RSV
infection.
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Human respiratory syncytial virus (RSV) is responsible for
approximately 64 million infections and 160,000 deaths
each year [1]. It is the most important cause of lower re-
spiratory tract (LRT) infections in young children and
neonates, and it is a significant cause of acute LRT-
associated death in young children in developing countries
[2]. In addition, several other high-risk groups include the
elderly and immunocompromised adults. This overall clin-
ical scenario is worsened by the lack of an available
vaccine and the limited availability of specific thera-
peutic drugs.
The mature RSV particle comprises a ribonucleopro-
tein (RNP) complex that is surrounded by a protein shell
formed by the matrix protein. The RNP complex con-
sists of viral genomic RNA (vRNA), the nucleocapsid
(N) protein, the phosphoprotein (P protein), M2-1 pro-
tein, and the large (L) protein [3-10]. The virus particle
is surrounded by a lipid membrane in which the attach-
ment (G) protein and fusion (F) proteins are inserted.
During virus entry the G protein mediates attachment of
the virus to the cell [11], while the F protein mediates
the fusion of the virus and host cell membrane [12].
Two distinct virus structures are formed in RSV-infected
epithelial cells that lead to a productive infection, called
virus filaments and inclusion bodies. The virus filaments
form at the plasma membrane on the surface of infected
cells and are sites where the virus structural proteins
interact to form mature filamentous virus particles. The
inclusion bodies are the sites in the cell where the RNP-
associated proteins and virus-specific RNA accumulate
[13-15], suggesting that inclusion bodies may be accu-
mulations of pre-assembled virus RNPs prior to pack-
aging into the progeny virus.
LRT infection due to RSV is a complicated process
and several cell types are implicated in the disease pro-
gression [16]. Disease severity due to extensive lung tis-
sue damage correlates with enhanced pro-inflammatory
cytokine secretion and inflammation. RSV infection of
macrophage cells in the lungs of severely infected pa-
tients has been demonstrated [17], and these immune
cells are proposed to play an important role in the early
response to RSV infection [18-20]. The murine animal
model system has been extensively used to examine the
pathology of RSV infection since it is generally represen-
tative of the disease progression in the LRT of humans
[17]. Several studies have employed blood monocyte de-
rived macrophage (BMDM) cells as a model system to
understand interactions between RSV and lung macro-
phages. However, the biological properties of macro-
phages is influenced by their tissue location [21],
suggesting that BMDM cells and pulmonary macrophage
cells may behave differently with respect to RSV infec-
tion. Since pulmonary macrophages play an importantrole during the initial stages of RSV infection we have
performed a detailed molecular and cellular characterisa-
tion of RSV infection in primary murine lung macrophage
cells. To obtain a better understanding of the interaction
of RSV with lung-derived primary murine macrophages
we also used a systems-based approach to examine the ef-
fect of RSV infection on the host transciptome during the
early and late stages of infection.
Results
RSV exhibits similar replication characteristics in alveolar
macrophage and pulmonary macrophage cells
Alveolar macrophage (AMΦ) cells represent a minor
population of the total pulmonary lung macrophage popu-
lation. However, although AMΦ cells may exhibit some
distinct biological properties from the total lung macro-
phage population, they are expected to exhibit broadly
similar tissue-specific biological properties to the bulk
lung macrophage population [22,23]. We isolated an aver-
age of 2x104 alveolar macrophage (AMФ) cells per mouse
from broncho-alveolar lavage fluid, and 1x106 pulmonary
macrophage (PMФ) cells per mouse were isolated from
whole lung tissue. These macrophage cell preparations
were stained using antibodies which recognise murine
macrophage antigenic markers CD11b, CD11c and F4/80
[24] and examined by fluorescence (IF) microscopy. Ap-
proximately 95% of the adhered cells showed CD11b and
F4/80 staining, confirming their murine macrophage ori-
gin (Additional file 1: Figure S1A and B). The AMΦ and
PMΦ cell preparations were infected with RSV and at 24
hpi, RSV-infected cells were stained with anti-RSV and
imaged using IF microscopy. The numbers of stained cells
(determined by fluorescence microscopy) and total cell
numbers (determined by bright field microscopy) in the
same field of view allowed an estimation of cell infection
levels. The presence of virus antigen in >95% of the cells
in either cell preparation indicated efficient infection
(Figure 1A), suggesting that each cell preparation was
similarly susceptible to RSV infection. The expression of
virus proteins in the virus-infected PMФ cells was further
confirmed by immunoblotting infected cell lysates using
anti-N, anti-P anti-G, anti-F(MAb169) and anti-M2-1
which revealed protein species of the expected sizes
(Figure 1B).
Virus-infected PMΦ cells were labelled either with anti-
F or anti-G and examined using fluorescence scanning
confocal microscopy (FSCM) (Figure 1C and D), which re-
vealed a structured punctuate staining pattern on the sur-
face of infected cells in each case. A similar staining
pattern was also observed on anti-F labelled RSV-infected
AMФ cells (Figure 1E). In permissive cell types such as
HEp2 cells the infectious particles form filamentous struc-
tures that allow cell to cell transmission. However, in both
cases this surface staining pattern observed in macrophage
Figure 1 (See legend on next page.)
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Figure 1 Lung macrophages are efficiently infected with RSV. (A) (i) PMΦ cells and (ii) AMΦ cells were mock-infected or RSV-infected, and
at 24 hrs post-infection (hpi) stained with anti-RSV and examined using fluorescence microscopy (objective x 10) (highlighted by white arrows).
(B) Mock (M) and RSV-infected (I) PMΦ cell lysates were examined by immunoblotting using anti-N, anti-P, anti-M2-1, anti-F or anti-G. Anti-actin is
shown as the loading control. Analysis of mock and RSV-infected HEp2 cells (using same cell numbers) with anti-F and anti-G is shown. Protein
bands of the expected sizes for the respective virus proteins are indicated. The 50 kDa F1 subunit, and the O- and N-linked (G(o/n)) and N-linked
(G (n)) glycosylated G proteins are indicated. PMΦ cells were infected with RSV and at 24 hpi the cells were fixed, labelled using (C) anti-F or (D)
anti-G and examined using florescence scanning confocal microscopy (FSCM) (i) at a focal plane that shows the cell surface staining (inset,
highlighted by *) or (ii) in cross-section showing the surface staining (highlighted by white arrow). (E) The AMΦ cells were stained using anti-F
and examined at a focal plane that shows the cell surface (inset, highlighted by *). (F) RSV-infected HEp2 cells at 24 hpi stained using anti-F
(inset) and examined using FSCM, the virus filaments (VF) on the cell surface are highlighted. (G) (i) Mock and (ii) RSV-infected cells were stained
with anti-RSV and anti-HSP90. The presence of virus-induced inclusion bodies and HSP90 staining of these structures is highlighted (white
arrows). (H) RSV-infected AMΦ cells were stained using anti-RSV, and the presence of stained inclusion bodies highlighted (white arrow). (I) At 24
hpi RSV-infected PMΦ cells were stained with anti-RSV and anti-LAMP-1. The inclusion bodies (IB) and the LAMP-1 punctate staining pattern
(white arrows) are highlighted.
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particles that form on the permissive HEp2 cell line
(Figure 1F). Scanning electron microscopy (SEM) revealed
the presence of membrane ruffling on both mock-and
virus-infected PMΦ cells, with increased membrane ruf-
fling following virus infection (Additional file 2: Figure
S2A). Similarly, transmission electron microscopy (TEM)
revealed numerous membrane protrusions on mock-
infected and RSV-infected cells (Additional file 2: Figure
S2B), with increased appearance of these structures on
virus-infected cells. Both electron microscopy techniques
indicated increased membrane ruffling during virus infec-
tion but the absence of progeny virus.
Examination of anti-RSV stained PMΦ cells revealed
cytoplasmic structures that were similar in appearance to
inclusion bodies (Figure 1G). The presence of heat shock
protein 90 (HSP90) within inclusion bodies has been
reported [25], and co-staining of infected PMΦ cells with
anti-RSV and anti-HSP90 indicated the presence of
HSP90 in these structures (Figure 1G (ii)). A similar stain-
ing pattern was also detected within RSV-infected AMФ
cells labelled with anti-RSV (Figure 1H). The PMΦ cells
exhibited phagocytic activity (Additional file 1: Figure
S1C), and the presence of LAMP1 in mature phagosomes
has been established [26]. To distinguish the inclusion
bodies from phagosomes the infected cells were co-
stained with anti-LAMP1 and anti-RSV, and examined
using FSCM (Figure 1I). Co-staining with anti-LAMP1
was not observed in these structures suggesting that the
anti-RSV staining pattern was due to inclusion bodies and
not phagocytosed virus antigen.
Similar vRNA levels at between 2.5 and 20 hpi were
detected (Additional file 3: Figure S3A) suggesting low
levels of vRNA synthesis. The virus infectivity recovered
in RSV-infected HEp2 and PMΦ cells was compared by
plaque assay which indicated virus titres of 3x106 pfu/ml
and 2x101 pfu/ml respectively. This low level of virus re-
covered from the infected PMΦ cells was likely due to
residual virus from the input virus inoculum. Similarlythe tissue culture supernatant (TCS) of RSV-infected
HEp2 and PMΦ cells was added to HEp2 cells and anti-
RSV stained cells detected using IF microscopy. An
abundance of stained cells was observed with the TCS of
the infected HEp2 cells indicating efficient progeny virus
production. In contrast using this assay we failed to ob-
serve stained cells using the TCS of RSV-infected AMΦ
cells and only sporadic stained cells were detected using
the TCS of RSV-infected PMΦ cells (Additional file 3:
Figure S3B).
Collectively although these data indicated that RSV in-
fection results in the formation of virus antigen and the
production of inclusion bodies, efficient infectious virus
particle production does not occur. This is consistent with
previous observations indicating abortive infection in lung
macrophages [27]. These data also suggest that the AMΦ
and PMΦ cells preparations behave similarly with respect
to challenge with RSV.
Global gene expression changes in RSV-infected
pulmonary macrophage (PMΦ) cells
Macrophage cell activation is associated with changes in
the macrophage transcriptome leading to cell reprogram-
ming [28,29]. The effect of RSV infection on the host cell
transcriptome was examined using the GeneChipWMouse
Genome 430 2.0 Array (Affymetrix) high density micro-
array system. This provides a sensitive method to monitor
virus-induced changes in the global gene expression pro-
file at the early stages in infection. The AMΦ and PMΦ
cell preparations behaved similarly with regards to RSV
infection, however due to logistical difficulties in obtaining
sufficient AMФ cells for the microarray analysis, the gene
expression analysis was restricted to the PMФ cell
preparation.
There are 28,974 annotated genes on the microarray
system, and analysis of the microarray data indicated
that 69.3% of the annotated genes were expressed in
mock-infected cells. This indicated that a relatively large
proportion of the total transcriptome was represented in
Figure 2 (See legend on next page.)
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Figure 2 Temporal global host cell expression changes during RSV-infection. (A) The genes showing up-regulated and down-regulated
gene expression that are unique to either 4 or 24 hrs post-infection (hpi) or common to both 4 and 24 hpi are indicated in the venn diagram. T
is the total number of genes at each time using the fold change cut-off. (B) The numbers of genes based on gene ontology showing up-
regulated or down-regulated expression in the microarray analysis of RSV-infected MΦ cells are summarized. The genes showing changes in
expression levels were filtered based on ≥2-fold, ≥5-fold and ≥10-fold changes (P≤ 0.05). Genes showing ≥10 fold down-regulated expression
following virus infection were not detected.
Figure 3 Different canonical pathways in RSV-infected PMФ cells based on macrophage host genes showing differential gene
expression (A) 4 and (B) 24 hours post-infection (hpi). The microarray data sets for each time of infection was processed using GeneSpring
GX 11.0 and uploaded into Ingenuity Pathways Analysis version 2012 (IPA). The data was filtered based on the significance cutoff ≤0.05 and fold
change cutoff ≥2. Genes were categorized using IPA, and p-values were calculated by Fisher’s exact test for each canonical pathway at 4 and 24
hpi, and the top 10 statistically significant canonical pathways were identified at each time of infection and listed. The number of genes listed for
each pathway is indicated in the parentheses. The orange boxes indicate the ratio (Ratio) of the numbers of genes that show changes in gene
expression data and the total number of genes in the respective canonical pathway. Threshold was set at p-value = 0.05 and indicated as –log
(p-value) on the Y-axis and the X-axis shows the terms of each canonical pathway.
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pression microarray at early (4 hpi) and late (24 hpi) stages
in the virus infection was analysed (Figure 2A). An 8.9%
change in the global host gene transcriptome was
observed at 4 hpi, with 1162 and 629 host genes showing
up-regulated and down-regulated gene expression respect-
ively. At 24 hpi this increased to 11.3% of the total host
cell transcriptome, with 1540 and 722 host genes showing
up-regulated and down-regulated gene expression respect-
ively. Collectively these data indicated that RSV infection
caused a relatively minor change in the global host-gene
expression profile by 24 hpi.
The genes showing virus-induced changes in expression
were filtered using the fold-change (FC) in expression
levels, which allowed us to distinguish the genes showing
a high FC in expression levels (>10 FC). A significant pro-
portion of genes showing changes in expression levels fol-
lowing RSV infection were uniquely expressed at either
time point. The genes showing up-regulated expression
and down-regulated expression following virus infection
were compared at both times of infection using a 2-FC
cut-off. Common up-regulated genes and down-regulated
genes accounted for 17.4% and 12.8% total gene changes
respectively. This suggested that distinct changes in host
cell transcriptome occurred at early and late stages in in-
fection. In general genes showing up-regulated expression
exhibited a higher fold-change (FC) in expression levels
compared to those genes showing down-regulated expres-
sion, and most differentially expressed genes showed a
higher FC at 24 hpi compared with that at 4 hpi. Based on
gene ontology the largest proportion of genes showing a
greater than 10-FC increase in expression levels were
functionally defined as cytokine, antiviral, signal transduc-
tion and cell-death related, while those showing the
greatest reduction in expression were signal transduction
and RNA binding (Figure 2B).
Gene enrichment analysis based on the global gene ex-
pression changes was performed using the ingenuity
pathway analysis (IPA). This was performed at each time
of infection, and the canonical pathways identified at
each time point were ranked based on the corresponding
p value (statistical significance) using a cut-off of p <
0.05. This enabled us to obtain a list of the 10 most sig-
nificant pathway groupings at 4 hpi (Figure 3A) and 24
hpi (Figure 3B). A comparison of the numbers of genes
showing changes in gene expression with the total num-
ber of genes in these canonical pathways indicated ratios
of between approximately 0.15 and 0.5 (i.e. between 15
and 50% of the total number of genes in these path-
ways). This indicated that a relatively large number of
genes were represented in these canonical pathways. Al-
though in general most pathways were represented at
each time of infection (e.g. pathways involving genes that
activate pathogen pattern recognition receptors), theirranking in the list varied (Additional file 4: Table S1).
Collectively, this analysis indicates that RSV infection in-
duces a range of antivirus responses in macrophages,
from those playing a role in initial host responses involv-
ing pathogen recognition, cytokine signalling (e.g. inter-
feron induction) and antigen presentation.
Our analysis indicated that genes and pathways that
were up-regulated were more highly represented in the
global gene analysis, both in terms of gene numbers and
FC in expression levels. To examine pathways that
showed down-regulated expression a pathway enrich-
ment analysis was performed on all genes that were
grouped separately into either up-regulated or down-
regulated expression at either time point. We generated
a pathway list showing the 15 most significant pathways
in each category (Additional file 5: Table S2). In the list,
antivirus response pathways were again more highly rep-
resented at both 4 and 24 hpi for pathways showing up-
regulated gene expression. In contrast, a similar pathway
enrichment analysis on genes showing down-regulated
expression indicated genes in pathways defined as in-
volved in rho signalling and virus entry via endocytosis
were more highly represented at 4 hpi. At 24 hpi path-
ways involved in cholesterol biosynthesis and lipid me-
tabolism were more highly represented, indicating that
by 24 hpi virus infection may also induce changes in
pathways playing a role in cellular metabolism.
Validation of selected gene expression changes in RSV-
infected pulmonary macrophage (PMΦ) cells
Since genes that play a role in the antivirus responses
showed the highest FC in gene expression we examined
the gene expression changes of specific antivirus networks
in more detail. These virus-induced changes in gene ex-
pression were also validated using independent bioche-
mical assays.
Cytokine gene expression
RSV infection was associated with increased expression
of several cytokine genes (Figure 4A). Increased expres-
sion of some specific cytokine genes (e.g. CCL4, IL-10,
TNF- α) could be detected at 4 hpi, which is consistent
with previous reports suggesting early detection of these
cytokines in RSV-infected cells [30-35]. However, in gen-
eral the levels of these early expressed cytokines declined
by 24 hpi. In contrast, other cytokines only showed in-
creased expression at 24 hpi (e.g. CCL5), indicating late
or delayed expression.
The protein levels of some specific cytokines were mea-
sured in the tissue culture supernatant TCS of mock-
infected and RSV-infected MΦ cells. Increased levels of
MIP-1α (CCL3), MIP-1β (CCL4), MCP-1(CCL2), IL1β,
IL1α, RANTES (CCL5), TNFα and IL-6 were observed by
24 hpi (Figure 4B). This was consistent with the increased
Figure 4 (See legend on next page.)
Ravi et al. BMC Genomics 2013, 14:190 Page 8 of 18
http://www.biomedcentral.com/1471-2164/14/190
(See figure on previous page.)
Figure 4 Changes in cytokine gene expression profiles in RSV-infected macrophage cells. (A) The fold change (FC) in cytokine gene
expression at 4 and 24 hours post-infection (hpi) is presented as a heat map. In each case the FC range, probe identification (Probe ID), and gene
name (Gene Title) are indicated. (B) Increased cytokine secretion in RSV-infected PMΦ cells. The PMФ cell preparation was either mock-infected or
infected using a RSV inoculum that was either non-treated (RSV) or UV-inactivated (RSV UV). At 24 hours post-infection the cytokine levels were
measured in the tissue culture supernatant. (C) The levels of specific cytokines persisted in RSV-infected PMΦ cells. Cells were infected with RSV
and the cytokine levels measured at between 24 and 96 hpi. In each case the tissue culture supernatant was harvested and the cytokine levels
measured using the Bio-Plex Mouse Cytokine 23-plex panel. The data shown were obtained from triplicate measurements, and representative
data from one of two independent experiments are shown.
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analysis. The cytokine levels in PMΦ cells challenged with
infectious virus (RSV-NT) and ultra-violet inactivated
virus (RSV-UVT) were compared to confirm that cytokine
secretion was dependant on the presence of infectious
virus. The HEp2 cell line is highly susceptible to RSV in-
fection and we failed to observe significant anti-RSV label-
ling of HEp2 cells that were challenged with RSV-UVT
confirming virus inactivation (Additional file 6: Figure S4).
Similar cytokine levels in the TCS of mock-infected and
RSV-UVT-infected cells were observed, and a comparison
of the cytokine levels induced in RSV-NT-infected and
RSV-UVT-infected PMΦ cells indicated 60% lower levels
in IL-6, and between a 100-fold and 1000-fold lower levels
of several other cytokines (e.g. RANTES and TNFα) in
cells challenged with RSV-UVT (Figure 4B). A similar
analysis on the RSV-infected AMΦ cells showed increased
MIP-1α, MIP-1β, RANTES levels and smaller increases in
IL6 and TNFα secretion when challenged with infectious
RSV. Mock-infected and RSV-UVT-infected cells showed
similar cytokine levels in the TCS, indicating that cytokine
induction only occurred in AMΦ cells challenged with in-
fectious virus (Additional file 7: Figure S5). Although the
levels of cytokines measured in the AMΦ cell preparation
were lower than that measured in the PMФ cell prepar-
ation, these data indicated the increased secretion of sev-
eral common pro-inflammatory cytokines in both cell
preparations that have been implicated in RSV-mediated
lung pathology in humans [34]. These data also indicated
that that infectious virus was required to induce these
changes in cytokine induction and cytokine signalling.
RSV-infected PMΦ cells were further examined to de-
termine if the increased cytokine levels could be
detected at later stages in the infection process. We ob-
served elevated levels of these cytokine in the TCS of
RSV-infected cells up to 96 hpi (Figure 4C). We used 96
hpi as the cut-off in this analysis since after this time we
noted significant deterioration in the appearance and
condition of the macrophage preparation. However, this
analysis indicated that the virus-induced increases in
cytokine levels were sustained even in the absence of sig-
nificant levels of progeny virus production. Although at
24 hpi some of the cytokine gene expression levels were
lower than that measured at 4 hpi, a sustained increasein cytokine gene expression at 24 hpi was still apparent,
which may partly account for the sustained cytokine
levels measured in the TCS.
Interferon type I signalling and interferon stimulated
gene expression (ISG)
Interferon proteins are important cytokine mediators of
the innate immune response, whose expression is induced
following recognition of specific pathogen-associated mo-
lecular patterns (PAMPs) by pattern recognition receptors
(PRRs). These PRRs include DExD/H 58, also known as
retinoic acid inducible gene I (RIG-I), and interferon-
induced helicase C domain-containing protein 1, also
known as melanoma differentiation-associated gene-5
(mda-5). A small increase in RIG-I and mda-5 gene ex-
pression was detected at 4 hpi, but significantly larger in-
creases in RIG-I and mda-5 gene expression was observed
by 24 hpi. The increased RIG-I and mda-5 gene expres-
sion correlated with a small initial increase in IFNα gene
expression (Figure 4A), but a significantly higher increase
in IFNβ gene expression. At 4 hpi a 150-FC in IFNβ gene
expression was recorded, which declined to a 17-FC in-
crease by 24 hpi. The microarray data was supported by
qPCR measurements of the IFNβ mRNA in mock and
virus-infected cells (Additional file 8: Figure S6 (i)), which
indicated an approximate 220-FC and 30-FC in expression
at 4 and 24 hpi respectively. Both methods showed the
same magnitude of gene expression changes, and similar
trends in gene expression changes. Although there was a
variation in FC values obtained using microarray analysis
and qPCR analysis, both methods showed consistent
trends in IFNβ gene expression. The differences observed
in FC values in gene expression levels obtained using these
two methods has been the subject of several reports
[36,37].
Increased Type I IFN (IFN α/β) expression would be
expected to lead to STAT-1 activation, and the activation
status of the STAT-1 in RSV-infected PMΦ cells was ex-
amined. RSV-infected cells were harvested at between 0.2
and 24 hpi and the presence of STAT-1 and phosphory-
lated STAT-1 (pSTAT-1) was detected at each time-point
by immunoblotting with appropriate antibodies (Figure
5A). Comparable levels of STAT-1 were detected at all the
time points examined, while pSTAT-1 was detected at
Figure 5 (See legend on next page.)
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Figure 5 Changes in interferon stimulated gene (ISG) expression and cell death signalling in RSV-infected macrophage cells. (A)
Activation of the STAT-1 signalling pathway in RSV-infected PMΦ cells. Cells were infected with RSV and at between 0.2 and 24 hrs post-infection
hpi the cells were harvested and the relative STAT-1 and PSTAT-1 levels determined by immunoblotting using relevant antibodies. (B) The fold
change (FC) in the expression of interferon stimulated genes and cell death signalling related genes at 4 and 24 hpi in virus-infected cells
compared with mock-infected cells is represented as a heat map. In each case the FC range, the probe identification (Probe ID) and gene name
(Gene Title) are indicated. (C) Activation of the JNK signalling pathway in RSV-infected PMΦ cells. Cells were infected with RSV and at between
0.2 hpi and 24 hpi the cells were harvested and the relative JNK and phosphorylated JNK levels determined by immunoblotting using relevant
antibodies. The mock-infected cell lysate (M) was harvested at 12 hpi.
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decline during the course of infection, a reduction in
pSTAT-1 levels was observed from between 12 and 24 hpi.
The reason for this reduction in pSTAT-1 is currently un-
certain, but was consistent with a decline in IFNβ mRNA
levels indicated by both the qPCR and microarray data.
Activation of the STAT-1 would be expected to lead to
the expression of several IFN stimulated genes (ISG)
(reviewed in [38]). Although the microarray analysis indi-
cated basal levels of ISG expression at 4 hpi, relatively
large increases in ISG expression levels was detected at 24
hpi (Figure 5B), which was consistent with STAT-1 activa-
tion. The increased ISGs detected included several ISGs
with relatively well characterized anti-virus activities (e.g.
Myxovirus (MX) protein and RSAD2), and several other
ISGs with less well characterized anti-virus activities (e.g.
IFN-induced protein 44). The microarray analysis was val-
idated using qPCR to compare the mRNA levels of several
selected ISGs in mock and infected cells (Additional file 8:
Figure S6 (i)).
Cell death signalling
The increased expression of XIAP associated factor 1
(XAF1) was detected in the microarray analysis (Figure 5B),
and XAF1 is a pro-apoptotic protein that inhibits the anti-
apoptotic activities of the XIAP [39,40]. JNK activation can
be mediated via Type I IFN signalling pathways [41], and
the role of ISG products have been implicated in p38 and
JNK activation [42,43]. Furthermore, XAF1 expression is
enhanced by activated JNK [44], and the activation status of
the JNK pathway was therefore examined in RSV-infected
MФ cells. Cells were infected with RSV and at between 12
mins post-infection and 24 hpi the presence of JNK and
phosphorylated JNK (pJNK) was detected (Figure 5C). Sig-
nificant pJNK levels was only detected at 6 hpi, the pJNK
levels appeared to decline by 24 hpi in a similar manner
which may be related to the decline in IFNβ mRNA levels
at 24 hpi. A role for JNK activation in regulating apoptosis
has been proposed (reviewed in [45]), and the correlation
between JNK activation and enhanced expression of XAF1
is consistent with JNK playing a role in the induction of
cell-death pathways in RSV-infected PMФ cells.Macrophage activation and antigen presentation gene
expression
Several genes involved in macrophage activation and anti-
gen presentation showed up-regulated gene expression at
24 hpi (Figure 6A). These genes included CD40 antigen,
macrophage activation 2 like gene expression, and trans-
porter 1 ATP-binding cassette (TAP1). The up-regulated
expression of several genes encoding proteosomal proteins
that play an important role in inflammation antigen pres-
entation [46,47] was also detected at 24 hpi. The micro-
array analysis was validated using qPCR, which showed an
approximate 35-fold increase in the CD40 and TAP1 gene
expression by 24 hpi (Additional file 8: Figure S6(ii)), con-
sistent with the gene enrichment analysis indicating the
presence of antigen-presentation pathways at 24 hpi.
Examination of infected cells by IF microscopy revealed
that inclusion bodies could be detected in virus-infected
PMФ cells up to 96 hpi (Figure 6B (i) and (ii),), indicating
that these virus structures persisted in infected macro-
phage cells at later times in the infection process, and even
in the absence of infectious virus production. The inclu-
sion bodies detected at 24 hpi were considerably smaller
than those observed in RSV-infected HEp2 cells at a simi-
lar time of infection (Figure 6B (iii)). This indicated a
slower rate of inclusion body formation in PMФ cells,
consistent with slow rates of vRNA gene transcription in
these cells. We noted that from 24 hpi an additional
diffuse anti-RSV staining pattern was observed which be-
came more prominent at 96 hpi (Figure 6B (ii), highligh-
ted by *). This was distinct from the more compact
staining pattern observed for inclusion bodies and we pre-
sumed that this alternative staining pattern could arise
due to the phagocytosis of virus antigen. Infected cells
were co-stained with anti-RSV and anti-LAMP1 and while
the inclusion bodies did not co-localise with anti-LAMP1
(Figure 6C), we noted extensive co-localisation of anti-
LAMP1 with these diffusely anti-RSV staining structures
(Figure 6D). This suggested that this alternative staining
pattern indicated sites within the cell where engulfment of
virus antigen by mature phagosomes occurs, and was
consistent with the up-regulated expression of several
genes involved in proteosomal degradation and antigen
presentation.
Figure 6 (See legend on next page.)
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Figure 6 Increased expression of genes involved in macrophage activation and antigen presentation occurs in RSV-infected
macrophage cells. (A) The fold change (FC) in the expression of cytokine at 4 and 24 hours post-infection (hpi) are compared with that in
mock-infected cells as a heat map. In each case, the FC range, probe identification (Probe ID), and gene name (Gene Title) are indicated. (B) RSV-
infected PMΦ cells were stained with anti-RSV and examined by fluorescence microscopy at (i) 24 hpi, 48 hpi and 72 hpi and (ii) 96 hpi. The
stained cells were examined using either the same camera exposure time or at a reduced exposure time (highlighted by *) to enable the
inclusion bodies (IB) to be viewed (at magnification x20). Inclusion bodies are highlighted (white arrow) and a more diffuse anti-RSV staining
pattern is highlighted (*). (iii) RSV-infected HEp2 cells stained using anti-RSV at 24 hpi. The IBs are highlighted (white arrow). (C) At 48 hpi RSV-
infected PMΦ cells were stained with anti-RSV and anti-LAMP-1. The inclusion bodies (IB) and the LAMP-1 punctate staining pattern (*) are
highlighted (D). Also shown is the co-staining pattern of anti-RSV and anti-LAMP-1 in the diffusely stained phagosomes (*) that predominates
latter in infection.
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Disease severity due to RSV infection is likely to be partly
determined by a combination of the genetic characteristics
of the host [48] and the capacity of different RSV strains to
induce pro-inflammatory cytokines[49]. In addition RSV
can cause a persistent infection in susceptible hosts correl-
ating with prolonged disease symptoms [50]. Histopath-
ology of fatal cases of RSV infection have demonstrated
infection of lung macrophage cells [17], although no evi-
dence for the presence of infectious RSV particles was
noted. Our observations are consistent with abortive repli-
cation in lung macrophages, and is consistent with in vitro
studies on mouse [27] and human lung macrophage cells
[51-53]. However, in contrast to these previous studies our
study demonstrated virus gene expression and the forma-
tion of inclusion bodies, the latter being a characteristic of
productive RSV infection. However, it appears that cellular
processes are activated during virus infection that block the
formation of infectious virus particles. Therefore, although
all the available data suggests that lung macrophages are
an important source of pro-inflammatory cytokines during
RSV infection, they may not significantly contribute to
virus propagation in the lower airway.
The capacity of RSV to overcome the IFN antivirus re-
sponse and replicate in epithelial cells has been described
[54,55]. The interaction between STAT-1 and STAT-2 is re-
quired for IFN signalling and these previous studies suggest
inhibition of type 1 interferon occurs by down-regulation of
STAT2 expression. The virus-induced STAT signalling that
we observe in RSV infected macrophages suggests that
down regulated expression of the STAT proteins did not
occur in lung macrophage cells. The precise mechanism
that leads to the inability of RSV to counter the IFN re-
sponse in pulmonary macrophage cells is currently unclear
and will require further examination. However, our data
suggests that infectious virus particles are required for in-
ducing the host response to infection, suggesting that initial
events related to an early stage in the RSV replication cycle
initiates the antivirus responses. The correlation between
IFN signalling and abortive infection suggests that this re-
sponse may play a role in restricting the formation of infec-
tious virus. The expression of several ISGs with provenanti-viral activities was recorded [56,57], but it is currently
unclear if one or more these ISGs block the formation of
mature RSV particles that leads to the abortive infection in
lung macrophages.
In addition to ISG expression we noted the up-regulated
expression of several genes involved in proteosomal degrad-
ation and antigen presentation. It is expected that this
process leads to the display of RSV-related peptides on the
surface of the macrophage cells (i.e. antigen presentation).
Although we were able to detect strong fluorescence stain-
ing of the virus surface glycoproteins on surface of infected
macrophages, we failed to detect the presence of similar
levels of the corresponding proteins by western blotting.
This suggests that the virus glycoproteins may undergo
proteolytic degradation, and since the expression of the
virus glycoproteins is required for generating infectious
virus this may also partly account for the abortive infection
in these cells. In contrast, the presence of numerous virus-
induced inclusion bodies was detected later in the virus in-
fection, suggesting that the polymerase associated proteins
persisted in infected cells. This was consistent with the
ready detection of the RNP-associated N, P and M2-1 pro-
teins by immunoblotting of cell lysates prepared from
infected cell lysates. The available data suggests that inclu-
sion bodies may represent sites of virus genome transcrip-
tion (and virus gene replication), and that sequestering
these proteins into the RNPs may protect these proteins
from proteosomal degradation during the initial phase of
infection (up to 24 hpi). Although the inclusion bodies are
largely engulfed within phagosomes during the later stages
of infection, the formation of these structures early in infec-
tion may provide increased resistance of the virus RNP-
associated virus proteins to proteosomal degradation. Thus
the presence of the inclusion bodies even in the presence of
a potent antivirus response may play a role in the persist-
ence of immunopathologic symptoms that have been
reported in RSV-infected mice [50].
Although recent evidence suggests that circulating RSV
strains exhibit slow rates of evolution [58], they may also
differ in their capacity to induce pro-inflammatory cyto-
kines [49]. Our analysis of the infected lung macrophage
cells indicates a sustained pro-inflammatory cytokine
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gests that strategies that can control the pro-inflammatory
response may be useful in the treatment of patients with
LRT RSV infection. Future studies will use the in vitro
macrophage cell system described here to characterise the
host response of different clinical strains. Careful analysis
of transcriptome responses in field isolates should improve
our understanding of the interaction between RSV and
macrophages during the initial stages of LRT infection.
This may lead to the identification of important cell sig-
nalling pathways that mediate the host anti-virus response
to infection, which in turn could lead to the identification
of novel drug targets to control the pro-inflammatory re-
sponses during RSV infection.
Conclusions
This is the first study that has used global gene expression
to examine the host response in RSV-infected murine lung
macrophages. Our data shows that although RSV challenge
leads to an abortive infection, virus antigen within inclusion
bodies are formed. RSV challenge leads to up-regulated ex-
pression of genes involved in pathogen recognition, inter-
feron signalling, inflammation and macrophage activation.
The sustained pro-inflammatory cytokine levels even in the
absence of a productive infection may help explain the per-
sistence of symptoms that are associated with LRTI. In
addition our data suggests that drugs that control the pro-
inflammatory response may be useful in the treatment of
patients with severe RSV infection.
Methods
Virus and tissue culture
The RSV A2 strain was used throughout this study and
was prepared using HEp2 cell culture [25]. RSV particles
were recovered from tissue culture media by centrifuga-
tion at 150,000g for 2 hr at 4°C, after which the virus was
gently and uniformly resuspended in an equal volume of
fresh DMEM with 2% FCS at 4°C. The infectivity of the
resulting inoculum was confirmed using a HEp2 cell
microplaque assay [59,60]. Unless specified the cells were
infected using a multiplicity of infection of 4. UV-
inactivated virus was prepared at 4°C by exposing the
virus inoculum (at a distance of 1cm) to a UV radiation
source (λ = 256 nm) for 30 mins. Murine lung CD11b +
cells were prepared from 6–8 weeks old special pathogen-
free (SPF) female Balb/c mice as described previously [61]
but with modifications. The lungs were digested with col-
lagenase D (1 mg/ml; Gibco) and single cell suspension
(0.5% BSA, 2mM EDTA, in 1XPBS) obtained was passed
through a 30 μm filter. CD11b + cells were purified using
CD11b microbeads and a LS positive selection column
(Miltenyi Biotec). Broncho-alveolar lavage was performed
to harvest aveolar macrophages (AMФ) cells from the
mouse lungs. The lungs were washed five times with 1mlPBS each time and the cells were isolated by centrifuga-
tion at 300g for 10mins. Cell viability assays were
performed using Trypan blue which confirmed greater
than 95% cell viability. The cells were cultured in L929 cell
conditioned (30%v/v) medium for 3 days at 37°C in 5%
CO2. Prior to use, the cells were washed using PBS to re-
move non-adherent cells which further enhanced the
purification of these cell preparations.
Ethical approval
This study was carried out in strict accordance with the
recommendations in the Guidelines on the Care and Use of
Animals for Scientific Purposes of the National Advisory
Committee for Laboratory Animal Research (NACLAR),
Singapore. The protocol was approved by the Institutional
Animal Care and Use Committee, National University of
Singapore (Approved Protocol Number: 046/09). All the
operations on animals were done after the euthanasia of
the animals by CO2 inhalation, and all efforts were made to
minimize animal suffering.
Antibodies and specific reagents
The use of the F protein (MAb 169), M2-1 protein, N pro-
tein and P protein antibodies have been described previ-
ously [62]. The anti-F was obtained from Geraldine Taylor
(IAH, UK), anti-G and anti-LAMP-1 were purchased from
Abcam, and anti-RSV (RCL3) from Novacastra Laborator-
ies. The HSP90 antibody was purchased from Santa Cruz
Laboratories. The CD11b-FITC and F4/80-FITC antibodies
were purchased from Miltenyi Biotec and Biolegend
respectively.
Immunofluorescence microscopy
Cells on 13 mm glass coverslips were fixed with 3%
paraformaldehyde (PFA) in PBS for 30 min at 4°C,
permeabilised using 0.1% saponin, and labelled using
virus-specific primary antibodies and the appropriate
secondary antibodies. The mouse and rabbit secondary
antibodies were purchased from Molecular Probes as de-
scribed previously [62]. The stained cells were mounted
on slides using Citifluor and visualized using either a
Nikon eclipse 80i fluorescence microscope, or a Zeiss
Axioplan 2 confocal microscope using appropriate ma-
chine settings. Cells stained with CD11b-FITC and F4/80-
FITC antibodies were labelled prior to PFA fixation.
Western blotting
Cell lysates were prepared in 1X boiling mix (1% SDS,
15% glycerol, 1% β-mercaptoethanol, 60mM sodium phos-
phate, pH 6 · 8) at 100°C for 2 min. The protein samples
were transferred by western blotting onto PVDF mem-
brane, which were blocked with PBS containing 5%(w/v)
skimed milk powder (Marvel™) as described previously
(McDonald et al. 2004). The membrane was incubated
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IgG (whole molecule) peroxidase conjugate (Sigma, USA).
The protein bands were visualized using the ECL protein
detection system (Amersham, USA), and the apparent
molecular masses were estimated using Kaleidoscope pro-
tein standards (Bio Rad, USA).
Cytokine assay
Supernatant from the macrophage cells were centrifuged
at 10,000g for 10min at 4°C after which the supernatant
was used for cytokine assay. Cytokines present in the
media were analysed with the Bio-Plex Protein Array Sys-
tem (BioRad) using the Bio-Plex Mouse Cytokine 23-Plex
Panel (1 x 96-well, # M60009RDPD, Bio-Rad) according
to the manufacturer’s instructions.
Real-time quantitative PCR
Total RNA was extracted from cells at 4°C using the
RNeasy kit (Qiagen, USA) and reverse-transcribed using
Superscript II (Invitrogen, USA). Primers for cell-specific
genes were designed using the Probefinder software
(http://qpcr.probefinder.com/organism.jsp) from the Uni-
versal Probe Library (UPL) Design Center (Roche). The
comprehensive list of primer and probe sequences are de-
tailed (Additional file 9: Table S3). Quantitative real-time
PCR (qPCR) was carried out with the iCycler System
(BioRad) following the protocol previously described
[63]. The sequences of the elongation factor EEF1A1
(H. sapiens) was used as the reference gene since. Both ab-
solute and relative quantification analysis were done using
comparative Ct (ΔΔCt method) [64]. The vRNA copy
number was determined as follows. Briefly, both N gene
representing the vRNA copy number and EF gene were
PCR-amplified, gel-extracted and quantified. Serial dilu-
tions of each were made and measured to determine the
Ct values. All copy numbers presented in the result are
calculated based on 104 EF copy number. Relative FC of
the host virus gene expression were calculated with re-
spect to the mock-infected cells and normalized with the
corresponding cell line’s EF gene.
Microarray analysis
The mouse genome-wide gene expression was examined
using the GeneChipW Mouse Genome 430 2.0 Array
(Affymetrix) high density microarray systems. The cells
were harvested at 4°C using RNAlater (Ambion) in PBS
buffer. Total RNA was extracted using the RNeasy minikit
(Qiagen). Double-stranded cDNA was synthesized from
3 μg of total RNA with the GeneChip One-Cycle cDNA
synthesis kit (Invitrogen, Affymetrix), followed by synthesis
of biotin-labelled cRNA using the GeneChip IVT labelling
kit (Affymetrix). After fragmentation, 15 μg of labelled
cRNA was hybridized to the arrays, which were washed
and stained using the GeneChip Fluidics Station 450(Affymetrix), and then scanned with the GeneChip scanner
3000 (Affymetrix). Quality control, GeneChip hybridization
and data acquisition were performed according to the
standard protocols available from Affymetrix. Norma-
lization using a global scaling strategy to a target intensity
of 500 was first performed using GCOS (v1.1, Affymetrix)
before uploading the .CHP data file into GeneSpring GX
11.0 (Agilent) for data analysis. Further normalizations were
carried out in GeneSpring: (a) per chip normalization to
the 50th percentile and (b) per gene normalization where
RSV-infected samples were normalized to mock-infected
samples. Genes were selected for statistical analysis
according to the following criteria: (i) only genes that were
flagged as present in all three replicates (mock- or RSV-
infected), and (ii) a FC of ≥2 or ≤ −2 between RSV- and
mock-infected samples in all triplicate microarray experi-
ments. Finally, a one-way analysis of variance (ANOVA) of
the above selected genes was performed with a P-value cut-
off of less than 0.05 to determine significantly up- and
down-regulated genes during RSV infection. The function,
biological processes and pathways of these genes were then
examined using the GeneSpring program. All microarray
data was deposited as MIAME-compliant data submissions
GSE31378 in the Gene Expression Omnibus. Functional in-
terpretation of differentially expressed genes was analyzed
and these genes were grouped based on their biological
function and cellular component as annotated by Gene
Ontology (GO). The known pathways of differentially
expressed genes associated with metabolism and signalling
were investigated by canonical pathway analysis using In-
genuity Pathways Analysis (IPA; Ingenuity Systems http://
www.ingenuity.com). Those differentially expressed genes
with known gene IDs and corresponding expression fold
changes were uploaded into the software. P-value was
used to determine the probability that the association
between the genes in the dataset and the canonical
pathway. IPA uses a right-tailed Fisher’s exact test to
calculate p-value for canonical pathway analysis, with a
p-value cut-off of ≤ 0.05.
Electron microscopy
a) Scanning electron microscopy. Cells grown on glass cov-
erslips were critically point dried (Polaron CPD) prior to
mounting on aluminium stubs and carbon-coated using an
Edwards sputter coater device [60]. The cells were visual-
ized with a Jeol 5600 using appropriate machine settings. b)
Transmission Electron Microscopy. Cells were processed as
described previously [60]. Briefly, cell monolayers were
pelleted in BEEM capsules (TAAB) and fixed with 2.5% (v/
v) glutaraldehyde in PBS at 4°C. The cell pellet was post-
fixed with 1% (w/v) osmium tetroxide solution (TAAB) and
dehydrated through a gradient of ethanol concentrations.
The cell pellet was infiltrated with epon 812 (TAAB
Laboratories), and heat polymerized at 65°C for 24 hr.
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(saturated in 50:50 ethanol/water), counter-stained with
lead citrate and examined in a Jeol 1400 transmission elec-
tron microscope.Additional files
Additional file 1: Figure S1. Antigenic characterization of lung
macrophage cells. (A) PMΦ cells were labelled using anti-CD11b and
anti-F4/80 and (B) AMΦ cells were labelled with anti-CD11b and anti-
CD11c and examined using immunofluorescence (IF) microscopy or
bright field microscopy (BF) (at magnification x10). (C) The PMΦ cells
exhibited phagocytic activity. Polystyrene latex beads (2.0-μm diameter)
(Sigma) were coated with BSA (Sigma Aldrich) as described previously
(May et al., 2000). Briefly, the beads were washed three times in PBS,
incubated with BSA (10mg/ml) at 4°C overnight with gentle rotation, and
then washed to remove excess BSA at room temperature for 1 hour with
rotation, and then washed again with PBS. The PMΦ cells were plated on
cover slips placed and the latex beads were added at approximately 20
particles/cell for 30 minutes at 330C. Non-internalized beads were
removed by washing with PBS, the cells fixed using 3% PFA in PBS and
visualized using an inverted fluorescent microscope (Nikon)
(objective x100).
Additional file 2: Figure S2. Ultrastructural analysis of RSV-infected
PMΦ cells by electron microscopy. Mock and RSV-infected MΦ cells at
24 hour post-infection (hpi) were processed for (A) scanning electron
microscopy (SEM) or (B) transmission electron microscopy (TEM).
Representative images are shown. Membrane ruffling and protrusions on
the surface of the MΦ cells imaged by SEM and TEM respectively are
highlighted (black arrows). SEM, magnification at x5,000;TEM,
magnification at x40,000.
Additional file 3: Figure S3. Infectious virus particles are not produced
in RSV-infected macrophages (A) The total RNA was extracted from RSV-
infected MΦ cells at 2.5 and 24 hpi and the vRNA levels estimated by
qPCR as described in methods. This is the average of 3 measurements
and p < 0.05. (B) The tissue culture supernatant (TCS) from mock-infected
or RSV-infected HEp2 cells or PMΦ cells was harvested at 24 hpi and
used to infect HEp2 monolayers. At 24 hpi the presence of infected cells
in the HEp2 cell monolyer was stained using anti-RSV and viewed by
fluorescence microscopy (anti-RSV) and bright field microscopy (BF)
(objective x10).
Additional file 4: Table S1. Pathway enrichment analysis based on
global macrophage host genes showing changes in gene expression
following RSV infection at 4 and 24 hpi. Macrophages were infected with
RSV at two different time points and IPA version 2012 software was
applied for pathway analysis. The 10 most significant canonical pathways
enriched by global gene expression (p-value ≤ 0.05 and FC ≥ 2) at 4 hpi
and 24 hpi are listed. Corresponding p-values, gene numbers and
individual genes are also indicated.
Additional file 5: Table S2. Pathway enrichment analysis based on
macrophage host genes showing up-regulated and down-regulated
gene expression following infection with RSV at 4 and 24 hpi.
Macrophages were infected with RSV at two different time points and
IPA version 2012 software was applied for pathway analysis. Significant
canonical pathways enriched by differentially up-regulated or down-
regulated genes (p-value ≤ 0.05 and FC ≥ 2) at 4 hpi and 24 hpi were
listed. Corresponding p-values, gene numbers and individual genes were
also represented. The pathway in bold indicated that it is commonly
enriched at both 4 hpi and 24 hpi.
Additional file 6: Figure S4. UV-treatment inactivates RSV infectivity.
The RSV inoculum was either non-treated (RSV-NT) or UV-treated (RSV-
UVT) and used to infect either HEp2 cells and at 24 hours post-infection
the cells were stained using anti-RSV and viewed using a Nikon eclipse
80i fluorescence microscope (objective x10).
Additional file 7: Figure S5. Cytokine induction in the murine alveolar
macrophage (AMФ) cell preparation. The AMФ cell preparation was eithermock-infected (Mock) or infected using a RSV inoculum that was either
non-treated (RSV) or UV-inactivated (RSV(UV)). The levels of pro-
inflammatory cytokines in the tissue culture supernatant (TCS) was
measured at 24 hrs post-infection (hpi). In each case the data shown
were obtained from triplicate measurements (p < 0.05) and representative
data from two independent experiments is shown.
Additional file 8: Figure S6. Validation in the differential gene
expression of selected genes in RSV-infected MΦ cells using qPCR. The
relative mRNA levels in mock and RSV-infected MΦ cells of (i) 2’,5’-
oligoadenylate synthase 2 (OAS2), radical S-adenosyl methionine domain
containing 2 (RSAD2), RANTES, Interferon-β (IFNβ) and 2’,5’-oligoadenylate
synthase-like genes (OASL) (insets show expression levels in mock-
infected cells) and (ii) TAP1, CD40. The average values obtained from
three independent measurements (p < 0.05) and representative data from
one experiment.
Additional file 9: Table S3. Primer and probes sequences designed for
real-time qPCR. Primer sequences and UPL probes (Roche) used for real-
time qPCR validation . RSV N gene, IFN-β1: interferon β; OAS2: 2’, 5’-
oligoadenylate synthase 2; OASL: 2’, 5’-oligoadenylate synthase-like;
RSAD2: radical S-adenosyl methionine domain containing 2; HMGCR: 3-
hydroxy-3-methyl-glutaryl-CoA reductase; CH25H: cholesterol 25-
hydroxylase; TAP1: Antigen peptide transporter 1; CD40:CD40; RANTES
(CCL5); EF: elongation factor.
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